We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (βClearmindβ or the "Company"), a clinical-stage biotech company focused on discovery...
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (βClearmindβ or the "Company"), a clinical-stage biotech company focused on discovery...
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (βClearmindβ or the "Company"), a clinical-stage biotech company focused on discovery...
Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (βClearmindβ or the "Company"), a clinical-stage biotech company focused on discovery and...
Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (βClearmindβ or the "Company"), a clinical-stage biotech company focused on discovery and...
Vancouver, Canada, June 20, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (βClearmindβ or the "Company"), a clinical-stage biotech company focused on discovery...
Vancouver, Canada, June 11, 2024 (GLOBE NEWSWIRE) -- Β Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (βClearmindβ or the "Company"), a clinical-stage biotech company focused on discovery...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.11 | 6.66666666667 | 1.65 | 1.83 | 1.573 | 178386 | 1.64532725 | CS |
4 | 0.17 | 10.6918238994 | 1.59 | 2.3 | 1.46 | 4794946 | 1.70016824 | CS |
12 | 0.56 | 46.6666666667 | 1.2 | 2.3 | 0.9512 | 2948744 | 1.56074584 | CS |
26 | 0.42 | 31.3432835821 | 1.34 | 2.3 | 0.9512 | 1704422 | 1.56485666 | CS |
52 | -10.651 | -85.8190315043 | 12.411 | 16.194 | 0.9205 | 1908730 | 3.3573683 | CS |
156 | -160.84 | -98.9175891759 | 162.6 | 183 | 0.9205 | 1415857 | 9.24593591 | CS |
260 | -160.84 | -98.9175891759 | 162.6 | 183 | 0.9205 | 1415857 | 9.24593591 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions